Management of panic disorder in the elderly

被引:0
作者
Pace, Maxime [1 ]
Heckendorn, Mathilde [1 ]
Aouizerate, Bruno [2 ]
Hanon, Cecile [1 ]
Seigneurie, Anne-Sophie [1 ]
Lavaud, Pierre [1 ]
Hozer, Franz [1 ]
De Raykeer, Rachel Pascal [1 ]
Guerin-Langlois, Christophe [1 ]
Cormier, Lucile [1 ]
De Raucourt, Helene Poncelin [1 ]
Limosin, Frederic [1 ,3 ,4 ]
Hoertel, Nicolas [1 ,3 ,4 ]
机构
[1] AP HP Ctr Univ Paris, Ctr Ressource Reg Psychiat Sujet Age CRRPSA, Serv Psychiat & Addictol Adulte & Sujet Age, DMU Psychiat & Addictol, Paris, France
[2] Univ Bordeaux, Ctr Reference Reg Pathol Anxieuses & Depress, Ctr Expert Depress Resistante,Fdn FondaMentall,Po, CH Charles Perrens,Lab Nutr & Neurobiol Integree, Bordeaux, France
[3] Univ Paris, Inserm U1266, Inst Psychiat & Neurosci Paris, Paris, France
[4] Univ Paris, Fac Med Paris Descartes, Paris, France
来源
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT | 2020年 / 18卷 / 03期
关键词
panic disorder; synthesis; treatment; antidepressants; elderly subject; GENERALIZED ANXIETY DISORDER; BEHAVIORAL-THERAPY; MENTAL-DISORDERS; OLDER-ADULTS; PLACEBO; EFFICACY; LIFE; MIRTAZAPINE; PREVALENCE; ALPRAZOLAM;
D O I
10.1684/pnv.2020.0878
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Panic disorder in the elderly is an understudied disorder, despite being associated with substantial functional impairment, diminished quality of life and increased suicide risk in this population. This disorder is likely to be underdiagnosed and sometimes inadequately treated in the absence of national and international guidelines for this vulnerable population. Few therapeutic trials have specifically focused on the efficacy and tolerability of pharmacologic and psychotherapy treatments for panic disorder in the elderly, and current approaches to detect and manage this disorder are mainly based on experts' opinion or extrapolation from data available in younger adults. This report aims to provide a summary of current knowledge on pharmacologic and psychotherapeutic treatments for panic disorder in the elderly, and to propose a medical treatment algorithm, which should be viewed as a tool that may contribute to the choice of treatment, especially for treatment-resistant older patients with panic disorder. The main results here are the emphasis on antidepressant treatment, like selective serotonin reuptake inhibitor (SSRI), restricted benzodiazepine usage, take care of drug interactions, and importance of psychotherapy like cognitive behavioral therapy (CBT).
引用
收藏
页码:295 / 304
页数:10
相关论文
共 50 条
  • [21] Alprazolam extended-release in panic disorder
    Rickels, K
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (07) : 1599 - 1611
  • [22] Milnacipran in Panic Disorder With Agoraphobia and Major Depressive Disorder: A Case Report
    Chen, Mu-Hong
    Liou, Ying-Jay
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (05) : 201 - 202
  • [23] Obstruction sleep apnoea and panic disorder.
    Vanek, Jakub
    Minarikova, Kamila Belohradova
    Prasko, Jan
    Genzor, Samuel
    Subova, Dana
    Hodny, Frantisek
    Pobeha, Pavol
    Bocek, Jonas
    Ociskova, Marie
    NEUROENDOCRINOLOGY LETTERS, 2023, 44 (02) : 86 - 96
  • [24] Management of Panic Disorder with Neurofeedback in Patients with Muscular Dystrophy: A Case Report
    Kim, Hye-Geum
    Koo, Bon-Hoon
    Lee, Seung Woo
    Cheon, Eun-Jin
    ALPHA PSYCHIATRY, 2021, 22 (04): : 219 - 221
  • [25] New treatment options for panic disorder: clinical trials from 2000 to 2010
    Freire, Rafael C.
    Hallak, Jaime E.
    Crippa, Jose A.
    Nardi, Antonio E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (09) : 1419 - 1428
  • [26] Effects of the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with Panic Disorder
    Zwanzger, P.
    Eser, D.
    Nothdurfter, C.
    Baghai, T. C.
    Moeller, H. -J.
    Padberg, F.
    Rupprecht, R.
    PHARMACOPSYCHIATRY, 2009, 42 (06) : 266 - 269
  • [27] Alterations of oral microbiota in patients with panic disorder
    Xie, Zunli
    Jiang, Weiqing
    Deng, Mingzhu
    Wang, Wei
    Xie, Xian
    Feng, Xia
    Shi, Yinping
    Zhang, Xueyan
    Song, Dong
    Yuan, Ziyu
    Wang, Yonggang
    BIOENGINEERED, 2021, 12 (01) : 9103 - 9112
  • [28] Mirtazapine versus fluoxetine in the treatment of panic disorder
    Ribeiro, L
    Busnello, JV
    Kauer-Sant'Anna, M
    Madruga, M
    Quevedo, J
    Busnello, EAD
    Kapczinski, F
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (10) : 1303 - 1307
  • [29] Panic attacks and panic disorder in the American Indian community
    Sawchuk, Craig N.
    Roy-Byrne, Peter
    Noonan, Carolyn
    Craner, Julia R.
    Goldberg, Jack
    Manson, Spero
    Buchwald, Dedra
    JOURNAL OF ANXIETY DISORDERS, 2017, 48 : 6 - 12
  • [30] Incidence of Panic Disorder Diagnoses After Celebrity Disclosures of Panic Disorder in South Korea
    Kim, Ga Eun
    Jo, Min-Woo
    Kim, Young Eun
    Yoon, Seok-Jun
    Shin, Yong-Wook
    JAMA NETWORK OPEN, 2024, 7 (07) : e2420934